Management of Von Willebrand Disease with Elevated Factor VIII Levels

Diagnostic Considerations

Elevated factor VIII levels may be due to various factors including stress, inflammation, pregnancy, or estrogen therapy, which can mask underlying VWD, according to the American Society of Hematology 1, 2
A complete VWD workup should include VWF:Ag, VWF:RCo, and the ratio of VWF:RCo/VWF:Ag to properly classify the type of VWD, as recommended by the American Society of Hematology 1, 3
Sample collection and processing conditions significantly affect test results - ensure proper handling at room temperature and prompt processing to avoid false results, as noted by the American Society of Hematology 2, 4
Patient factors that can elevate VWF and FVIII levels include stress, recent exercise, inflammatory illness, pregnancy, and oral contraceptives, according to the American Society of Hematology 2, 3

Response to desmopressin should be documented with pre- and post-treatment VWF and FVIII levels, as recommended by the American Society of Hematology 1, 2
Target VWF activity level should be ≥50 IU/dL for most procedures, according to the International Society on Thrombosis and Haemostasis 5, 6

VWF activity target for major surgery or severe bleeding should be ≥50 IU/dL, as recommended by the International Society on Thrombosis and Haemostasis 5, 6
VWF activity should be ≥50 IU/dL before neuraxial procedures, according to the International Society on Thrombosis and Haemostasis 5, 6
Maintain VWF activity >50 IU/dL while epidural catheter remains in place, as recommended by the International Society on Thrombosis and Haemostasis 6

Elevated FVIII with normal VWF activity (>50 IU/dL) generally does not require additional treatment for hemostasis, according to the International Society on Thrombosis and Haemostasis 5, 6
If VWF activity is low despite elevated FVIII, treatment should focus on correcting VWF deficiency, as recommended by the International Society on Thrombosis and Haemostasis 6, 7
Elevated FVIII may potentially increase thrombotic risk, though this must be balanced against bleeding risk from VWD, as noted by the American Gastroenterological Association 8

For surgical patients, monitor VWF:RCo, VWF:Ag, and FVIII levels pre-treatment, post-treatment, and periodically during treatment, as recommended by the American Society of Hematology 2
For persistent mucosal bleeding despite adequate FVIII levels, consider adjunctive treatments like tranexamic acid, according to the American Society of Anesthesiologists 9

Relying solely on FVIII levels for treatment decisions - VWF activity is the critical parameter, as noted by the American Society of Hematology 1
Failure to repeat testing under optimal conditions - stress, inflammation, and sample handling can significantly affect results, according to the American Society of Hematology 2, 4